Methods of treating a tumor that expresses APRIL by administering BCMA
US7276241B2 · kind B2 · utility
15Cited by
7References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 2, 2002 |
| Grant date | Oct 2, 2007 |
| Priority date | — |
| Expiry date | Oct 3, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel receptor in the TNF family is provided: APRIL-R. Chimeric molecules and antibodies to APRIL-R and methods of use thereof are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.